Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,607,513 | 3,800,000 | 2,818,000 | 3,078,000 | N/A |
| Marketable Securities | 545,163 | 344,000 | 508,000 | 570,000 | N/A |
| Receivables | 3,092,553 | 3,256,000 | 3,193,000 | 3,462,000 | N/A |
| Inventories | 1,427,854 | 1,313,000 | 1,364,000 | 1,364,000 | N/A |
| Income taxes - deferred | N/A | N/A | 657,000 | N/A | N/A |
| Other current assets | 117,135 | 154,000 | 260,000 | 1,051,000 | 0 |
| TOTAL | $8,790,218 | $8,867,000 | $8,800,000 | $9,525,000 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,846,108 | 1,859,000 | 2,324,000 | 2,429,000 | N/A |
| Investments And Advances | 1,020,092 | 940,000 | 666,000 | 745,000 | 0 |
| Intangibles | 3,932,847 | 3,854,000 | 3,137,000 | 0 | 0 |
| Other Non-Current Assets | 732,295 | 531,000 | 451,000 | 4,382,000 | 0 |
| TOTAL | $7,531,342 | $7,184,000 | $6,578,000 | $7,556,000 | $N/A |
| Total Assets | $16,321,560 | $16,050,000 | $15,378,000 | $17,081,000 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,062,078 | 1,816,000 | 2,027,000 | 2,327,000 | 0 |
| Accrued Expenses | N/A | N/A | 1,052,000 | 1,036,000 | N/A |
| Other current liabilities | 1,627,317 | 1,353,000 | 256,000 | 166,000 | N/A |
| TOTAL | $3,830,099 | $3,308,000 | $3,335,000 | $3,831,000 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 492,383 | 419,000 | 376,000 | 457,000 | 0 |
| TOTAL | $498,425 | $426,000 | $745,000 | $834,000 | $N/A |
| Total Liabilities | $4,328,524 | $3,734,000 | $4,080,000 | $4,665,000 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 937,309 | 1,000,000 | 1,096,000 | 1,256,000 | N/A |
| Retained earnings | 8,236,255 | 8,396,000 | 9,761,000 | 10,912,000 | N/A |
| Other shareholders' equity | 2,002,396 | 1,731,000 | -671,000 | -1,626,000 | 0 |
| TOTAL | $11,993,040 | $12,315,000 | $11,298,000 | $12,416,000 | $N/A |
| Total Liabilities And Equity | $16,321,564 | $16,049,000 | $15,378,000 | $17,081,000 | $0 |